Effect of Cassia sieberiana DC (Fabaceae) on α-amylase and α-Glucosidase and Diabetes Treatment Trial in Rats

Sadat, Baba O. Zeine Mohamed Anouar and Marcelin, Kouassi Konan Armand and Denis, Bedou Kouassi and Angèle, Edjeme-Ake and Hmeyada, Abdellahi Mohamed Vall and Salihi, Ahmedou Mohamed Vadel and Joseph, Djaman Allico and Jean-David, N’guessan (2023) Effect of Cassia sieberiana DC (Fabaceae) on α-amylase and α-Glucosidase and Diabetes Treatment Trial in Rats. International Journal of Biochemistry Research & Review, 32 (9). pp. 11-22. ISSN 2231-086X

[thumbnail of Sadat3292023IJBCRR108642.pdf] Text
Sadat3292023IJBCRR108642.pdf - Published Version

Download (363kB)

Abstract

Background: Diabetes is a metabolic disease caused by a disturbance in the regulation of carbohydrate metabolism. It constitutes a public health problem whose major symptom is chronic hyperglycemia. The present study aims to assess the inhibitory effect of aqueous root extract of Cassia sieberiana (AECs) on two glycosidases, as well as its anti-diabetic potential in Wistar rats.

Study Design: Experimental Design.

Place and Duration of Study: Biology and Health Laboratory, Training and Research Unit Biosciences, Félix Houphouët-Boigny University of Abidjan, Côte d’Ivoire, is the place where this study was carried out. The work was conducted from November 2022 to February 2023.

Methodology: The inhibitory effect of AECs on α-amylase and α-glucosidase was determined in vitro by measuring its ability to block the activity of these enzymes in the presence of their substrate. As for anti-diabetic activity, this was assessed in Wistar rats during experimental alloxane-induced diabetes. Diabetic rats were then treated with AECs at doses of 25 and 50 mg/kg bw and glibenclamide at a dose of 10 mg/kg bw for three weeks.

Results: AECs exerts weak inhibitory effect on α-amylase activity (IC50 = 3.41x104 mg/mL) compared to its effect on α-glucosidase activity (IC50 =7.31x10-2 mg/mL). However, this inhibitory effect is lower than that of acarbose (IC50 = 3.13x10-4 mg/mL). In addition, treatment of diabetic rats reduced hyperglycemia by 38.75%, 55.48% and 63.55% in rats receiving AECs at doses of 25 and 50 mg/kg bw and glibenclamide respectively. In addition, changes in lipid, hepatic and renal profiles, and weight loss in diabetic rats were corrected by this extract.

Conclusion: AECs inhibits α-glucosidase and α-amylase activity, but this effect is better with α-glucosidase. This extract is also able to reduce glycemia in diabetic rats and regulate certain parameters linked to complications associated with diabetes.

Item Type: Article
Subjects: STM Library > Biological Science
Depositing User: Managing Editor
Date Deposited: 22 Nov 2023 04:24
Last Modified: 22 Nov 2023 04:24
URI: http://open.journal4submit.com/id/eprint/3353

Actions (login required)

View Item
View Item